Integrated transcriptomic analysis and experimental validation identify ACADL as a mitochondrial tumor suppressor via the FOXO3a/PUMA axis in lung adenocarcinoma.

BACKGROUND: Mitochondrial dysfunction represents a recognized hallmark of cancer; however, the underlying molecular mechanisms contributing to this process in lung adenocarcinoma (LUAD) remain incompletely understood. METHODS: Differentially expresse…

Preview only. Read the full abstract at the source